Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,567 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cryobiopsy: A Breakthrough Strategy for Clinical Utilization of Lung Cancer Organoids.
Park D, Lee D, Kim Y, Park Y, Lee YJ, Lee JE, Yeo MK, Kang MW, Chong Y, Han SJ, Choi J, Park JE, Koh Y, Lee J, Park Y, Kim R, Lee JS, Choi J, Lee SH, Ku B, Kang DH, Chung C. Park D, et al. Among authors: kim r, kim y. Cells. 2023 Jul 14;12(14):1854. doi: 10.3390/cells12141854. Cells. 2023. PMID: 37508518 Free PMC article.
Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors.
Kim R, Keam B, Kim S, Kim M, Kim SH, Kim JW, Kim YJ, Kim TM, Jeon YK, Kim DW, Chung DH, Lee JS, Heo DS. Kim R, et al. Among authors: kim yj, kim dw, kim sh, kim s, kim m, kim tm, kim jw. BMC Cancer. 2019 Jan 7;19(1):19. doi: 10.1186/s12885-018-5214-8. BMC Cancer. 2019. PMID: 30616523 Free PMC article.
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer.
Kwon M, Kim G, Kim R, Kim KT, Kim ST, Smith S, Mortimer PGS, Hong JY, Loembé AB, Irurzun-Arana I, Koulai L, Kim KM, Kang WK, Dean E, Park WY, Lee J. Kwon M, et al. Among authors: kim st, kim g, kim km, kim r, kim kt. J Immunother Cancer. 2022 Jul;10(7):e005041. doi: 10.1136/jitc-2022-005041. J Immunother Cancer. 2022. PMID: 35790315 Free PMC article. Clinical Trial.
Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer.
Kim H, Kim H, Kim R, Jo H, Kim HR, Hong J, Park JO, Park YS, Kim ST. Kim H, et al. Among authors: kim st, kim r, kim hr. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211062324. doi: 10.1177/15330338211062324. Technol Cancer Res Treat. 2021. PMID: 34855561 Free PMC article.
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy.
Kim R, Kwon M, An M, Kim ST, Smith SA, Loembé AB, Mortimer PGS, Armenia J, Lukashchuk N, Shah N, Dean E, Park WY, Lee J. Kim R, et al. Among authors: kim st. Ann Oncol. 2022 Feb;33(2):193-203. doi: 10.1016/j.annonc.2021.10.009. Epub 2021 Oct 25. Ann Oncol. 2022. PMID: 34710570 Free article. Clinical Trial.
Early Tumor-Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer.
Kim R, An M, Lee H, Mehta A, Heo YJ, Kim KM, Lee SY, Moon J, Kim ST, Min BH, Kim TJ, Rha SY, Kang WK, Park WY, Klempner SJ, Lee J. Kim R, et al. Among authors: kim st, kim km, kim tj. Cancer Discov. 2022 Apr 1;12(4):984-1001. doi: 10.1158/2159-8290.CD-21-0888. Cancer Discov. 2022. PMID: 34933901 Free PMC article.
4,567 results